Rasayana herbs of ayurveda to treat age related cognitive decline: An update

Pharmacognosy Journal

Volumn 8, Issue 5, 2016, Pages 411-423

  Kulkarni, Reena ^a   Shetty, Suhas Kumar ^a   Rajarajeshwari, N M ^a   Narasimha Rao, Prasanna ^a   Nayan, J ^b  

^a SDM College of Ayurveda   (India)

^b Sri Kalabairaveshvara Swamy Ayurveda Medical College   (India)

Author keywords

Ayurveda; Cognitive decline; Dementia; Herbs; Medhya; Rasayana

Indexed keywords

AYURVEDIC DRUG; CURCUMIN; HERBACEOUS AGENT; NOOTROPIC AGENT; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ACORUS CALAMUS; ARTICLE; AYURVEDA; BACOPA MONNIERI; BENINCASA HISPIDA; CELASTRUS PANNICULATA; CENTELLA ASIATICA; COGNITIVE DEFECT; CONVOLVULUS PLEURICAULIS; CURCUMA LONGA; EMBLICA OFFICINALIS; GLYCIRRHIZA GLABRA; MEDICINAL PLANT; NARDOSTACHYS JATAMAMSI; NONHUMAN; TERMINALIA CHEBULA; TINOSPORA CORDIFOLIA; VELVET BEAN; WITHANIA SOMNIFERA;

EID: 85021176268     PISSN: None     EISSN: 09753575     Source Type: Journal    
DOI: 10.5530/pj.2016.5.1     Document Type: Article

References (230)

1. World Alzheimer Report 2009. London, Alzheimer Disease International, 2009. Neurological disorders: public health challenges. Geneva, World Health Organization, 2006.
2. Blennow K, de Leon MJ, Zetterberg H. Alzheimer disease. Lancet. 2006; 368 (9533):387-403.
3. Waring SC, Rosenberg RN. Genome-wide association studies in Alzheimer disease. Arch Neurol. 2008; 65(3):329-34.
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th edition). Arlington, Va.: American Psychiatric Publishing; 2013.
5. Nadkarni, K.M., 1993. Indian Materia Medica. Popular Prakashan Private, Bombay.
6. Agnivesha. Caraka Samhita with Chakrapani's Ayurveda Deepika Teeka. Acharya Y T, editor. Varanasi: Choukhamba Samskrita Samsthana; 1994. p. 38.
7. Grover IS, Kaur S. Effect of Emblica officinalis Gaertn: (Indian gooseberry) fruit extract on sodium azide and 4-nitro-O-phenylenediamine induced muta-genesis in Salmonella typhimurium. Indian Journal of Experimental Biology. 1989; 27(3):207-09.
8. Grover IS, Kaur S. Effect of Emblica officinalis Gaertn. (Indian gooseberry) fruit extract on sodium azide and 4-nitro-O-phenylenediamine induced mut agenesis in Salmonella typhimurium. Chemical Abstract 111, 17230h. 1989; 27(3):207-9.
9. Suresh K, Vasudevan DM. Augmentation of murine natural killer cell and antibody dependent cellular cytotoxicity activities by Phyllanthus emblica, a new immunomodulator. Journal of Ethnopharmacology. 1994; 44(1):55-60.
10. Thakur C P, Mandal K. Effect of Emblica officinalis on cholesterol-induced atherosclerosis in rabbits. Indian Journal of Medical Research. 1984; 790:142-6.
11. Thakur C P. Emblica officinalis reduces serum, aortic and hepatic cholesterol in rabbits. Experientia. 1985; 41(3):423-4.
12. Mathur R, Sharma A, Dixit V P, Varma M. Hypolipidaemic effect of fruit juice of Emblica officinalis in cholesterol-fed rabbits. Journal of Ethnopharmacology. 1996; 50(2):61-68.
13. Gulati RK, Agarwal S, Agrawal SS. Hepatoprotective studies on Phyllanthus emblica L. and quercetin. Indian Journal of Experimental Biology. 1995; 33(4):261-8.
14. Dwivedi Vibha, Tripathi K, Bipin Mutsuddi Mousumi and Lakhotia C Subhash. Ayurvedic Amalaki Rasayana and Rasa Sindoor suppress neurodegeneration in fly models of Huntington's and Alzheimer's diseases. Current science 2013; 105(12):1711-23.
15. Govindarajan M, Vijayakumar P, Pushpangadan. Antioxidant approach to disease management and the role of 'Rasayana' herbs of Ayurveda. Journal of Ethno-pharmacology. 2005; 99(2):165-78.
16. Saha S, Verma RJ. Antioxidant activity of polyphenolic extract of Terminalia chebula Retzius fruits. J Taibah Univ Sci. 2015.(article in press)
17. Grover IS, Bala S. Antimutagenic activity of T. chebula (myrob-lan) in Salmonella typhimurium, Ind. J. Exp. Biol. 1992; 30(4):339-41.
18. Chattopadhyay RR, Bhattacharyya SK., Plant review Termina-lia chebula: an update. Pharmacog Rev. 2007; 1(1):151-6.
19. Kapoor LD. Hand book of Ayurvedic Medicinal plants. CRC Press, Washington, DC, 2001; 18-19.
20. Puri HS. 2003. 'Rasayana'-Ayurvedic herbs for longevity and rejuvenation. Taylor and Francis, London.
21. Naik GH, Priyadarsini KI, Satav JG, Banavalikar MM, Sohoni D P, Biyani MK, Mohan H. Comparative antioxidant activity of individual herbal components used in Ayurvedic medicine. Phytochemistry. 2003; 63(1):97-104.
22. Cheng H Y, Lin TC, Yu KH, Yang CM, Lin CC. Antioxidant and free radical scavenging activities of Terminalia chebula. Biological and Pharmaceutical Bulletin 2003; 26(9):1331-5.
23. Nageswara rao S, Palaksha MN, Satish S, Ravishankar. The effects of Ethanolic Extract in Dried Fruits of Terminalia chebula on learning and memory in mice. Asian Journal of Biomedical and Pharmaceutical Sciences. 2013; 3(20):59-62.
24. Chia Lin Chang, Che San Lin. Phytochemical Composition, Antioxidant Activity, and Neuroprotective Effectof Terminalia chebula Retzius Extracts. Evidence-Based Complementary and Alternative Medicine. 2012; 1-7.
25. Part 1. Vol. Delhi: Controller of Publications. The Ayurvedic Pharmacopoeia of India. 2004; 83(4):62-3.
26. Aggarwal BB, Sundaram C, Malani N, Ichikawa H. "Curcumin: the Indian solid gold,". Advances in Experimental Medicine and Biology. 2007; 59(5):1-75.
27. Ganguli M, Chandra V, Kamboh MI. et al, "Apolipoprotein E polymorphism and Alzheimer disease: the Indo-US crossnational dementia study,". Archives of Neurology. 2000; 57(6):824-30.
28. Ng T P, Chiam PC, Lee T, Chua HC, Lim L, Kua EH. Curry consumption and cognitive function in the elderly. American Journal of Epidemiology. 2006; 164(9):898-906.
29. Park SY, Kim HS, Cho EK. et al. Curcumin protected PC12 cells against beta-amyloid-induced toxicity through the inhibition of oxidative damage and tau hyperphosphorylation. Food and Chemical Toxicology. 2008; 46(8):2881-7.
30. Zhang L, Fiala M, Cashman J. et al. Curcuminoids enhance amyloid-β uptake by macrophages of Alzheimer's disease patients. Journal of Alzheimer's Disease. 2006; 10(1):1-7.
31. Kim H, Park BS, Lee KG. et al. "Effects of naturally occurring compounds on fibril formation and oxidative stress of β-amyloid,". Journal of Agricultural and Food Chemistry. 2005; 53(22):8537-41.
32. Ono K, Hasegawa K, Naiki H, Yamada M. Curcumin has potent anti-amyloidogenic effects for Alzheimer's β-amyloid fibrils in vitro. Journal of Neuroscience Research. 2004; 75(6):742-50.
33. Yang F, Lim G P, Begum AN. et al. "Curcumin inhibits formation of amyloid β oligomers and fibrils, binds plaques, and reduces amyloid in vivo,". Journal of Biological Chemistry. 2005; 280(7):5892-901.
34. Shimmyo Y, Kihara T, Akaike A, Niidome T, Sugimoto H. Epigallocatechin-3-gallate and curcumin suppress amyloid beta-induced beta-site APP cleaving enzyme-1 upregulation. Neuro Report. 2008; 19(13):1329-33.
35. Lin R, Chen X, Li W, Han Y, Liu P, Pi R. Exposure to metal ions regulates mRNA levels of APP and BACE1 in PC12 cells: blockage by curcumin. Neuroscience Letters. 2008; 440(3):344-7.
36. Lim G P, Chu T, Yang F, Beech W, Frautschy SA, Cole GM. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer trans-genic mouse. Journal of NeuroScience. 2001; 21(21):8370-7.
37. Kim J, Lee HJ, Lee KW. Naturally occurring phytochemicals for the prevention of Alzheimer's disease. J Neurochem. 2010; 112(6):1415-30.
38. Elaine Perry, Melanie-Jayne R. Howes. Medicinal Plants and Dementia Therapy: Herbal Hopes for Brain Aging?. CNS Neuroscience & Therapeutics. 2011; 17(6):683-98.
39. Garcia-Alloza M, Robbins EM, Zhang-Nunes SX. et al. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiology of Disease. 2006; 24(3):516-24.
40. Cheng KK, Yeung C F, Ho SW, Chow S F, Chow AH, Baum L. "Highly stabilized curcumin nanoparticles tested in an in vitro blood-brain Barrier model and in Alzheimer's disease Tg2576 mice. The AAPS Journal. 2013; 15(2):324-36.
41. Ma Z, Shayeganpour A, Brocks DR, Lavasanifar A, Samuel J. High-perfor-mance liquid chromatography analysis of curcumin in rat plasma: application to pharmacokinetics of polymeric micellar formulation of curcumin. Biomedical Chromatography. 2007; 21(5):546-52.
42. Liu A, Lou H, Zhao L, Fan P. Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcumin. Journal of Pharmaceutical and Biomedical Analysis. 2006; 40(3):720-27.
43. Yu Z F, Kong LD, Chen Y. Antidepressant activity of acqueous extracts of curcumalonga in mice. Journal of ethno pharmacology. 2002; 83(1):161-65.
44. Shrinivas KK, Mohit KB, Mahendra B. Antidepressant activity of curcumin: involvement of serotonin and dopamine system. Psycho-pharmacology. 2008; 201(3):435-42.
45. Natascia B, Simona Re, Annalisa B, Antonella C, Niccolò L, Francesco B, Pierluigi P. Curcumin as a Therapeutic Agent in Dementia: A Mini Systematic Review of Human Studies. The Scientific World Journal. 2014; 161-5
46. Kim DSHL, Park SY, Kim J Y. Curcuminoids from curcuma long L. (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from ß A(1-42) insult. Neuroscience Letters. 2001; 303(1):57-61.
47. Park SY, Kim DSHL. Discovery of natural products from curcuma longa that protects cells from beta-amyloid insult: a drug discovery effort against Alzheimer's disease. Journal of natural products. 2002; 65(9):1227-31.
48. Kim DSHL and Kim J Y. Total synthesis of calebin-A, preparation of its analogues, and their neuronal cell protectivity against amyloid insult. Bioorganic and Medicinal Chemistry Letters. 2001; 11(18):2541-43.
49. Priyadarshini KL. Free radical reactions of curcuin in membrane models. Free radicalbiology and medicine with anti oxidant activity. Journal of Ehno Pharmacology. 2000; 71:23-43.
50. scartezzini P, Speroni E. Review on some plants of Indian traditional medicine with antoxidant activity. Journal of Ethnopharmacology. 2000; 71(1):23-43.
51. Das KC, Das K. curcumin (diferuloymethane), a singlet oxygen (O-1(2)) quencher. Biochemical and Biophysical Research Communications 2002; 295(1):62-6.
52. miquel J, Bernd A, Sempere JM, Diaz Alperi J, Ramirez A. The curcuma antioxidants: Pharmacological effects and prospects for future clinical use. A Review Archive of Gerentology and Geriatrics. 2002; 34(1):37-46.
53. Sharma PC, Yelne MB, Dennis TJ. Database on Medicinal plants used in Ayurveda and Sidha. Vol. 1. New Delhi: CCRAS, Dept. of AYUSH, Ministry of Health and Family Welfare. Govt of India. 2000; 264-79.
54. Acharya Y T, editor. Caraka Samhita with Chakrapani's Ayurveda Deepika Teeka. Varanasi: Choukhamba Samskrita Samsthana. Agnivesha. 1994; 385.
55. Sharma PC, Yelne MB, Dennis TJ. Database on Medicinal plants used in Ayurveda and Sidha. New Delhi: CCRAS, Dept. of AYUSH, Ministry of Health and Family Welfare, Govt. of India. 2005; 1:265-6.
56. Ramanathan M, Sivakumar S, Anand Vijayakumar PR, Saravanababu C, Rathinavel Pandian P. Neuroprotective evaluation of standardized extracts of Centella Asiatica in monosodium glutamate treated rats. Indian J Exp Biol. 2007; 45(5):425-31. [PubMed: 17569283]
57. Anbuganapathi GA. Synergetic effect of Vallarai and Brahmi on learning ability of albino mice and school children. Ootacamund: Paper presented at the International Seminar on Recent Trends in Pharmaceutical Sciences. 1995. pp. 18-20.
58. Mohandas Rao KG, Muddanna Rao S, Gurumadhva Rao S. Centella Asiatica (L.) Leaf Extract Treatment during the Growth Spurt Period Enhances Hippo-campal CA3 Neuronal Dendritic Arborization in Rats. eCAM. 2006; 3(3):349-57. [PMCID: PMC1513148] [PubMed: 16951719].
59. + - ATPases in rat brain during pentylenetetrazol-induced epilepsy. Indian J Pharmacol. 2010; 42(2):82-6. [PMCID: PMC2907020] [PubMed: 20711371]
60. Russo A, Borrelli F. Bacopa monniera, a reputed nootropic plant: An overview. Phytomed. 2005; 12(4):305-17.
61. Kumar A, Kulkarni SK. Protective effect of BR-16A, a polyherbal preparation against social isolation stress: Possible GABAergic mechanism. Phytother Res. 2006; 20(7):538-41. [PubMed: 16691632]
62. Anand T, Naika M, Kumar PG, Khanum F. Antioxidant and DNA Damage Preventive Properties of Centella Asiatica (L) Urb. Phcog J. 2010; 2(17):53-8.
63. Veerendra Kumar MH, Gupta YK. Effect of Centella Asiatica on cognition and oxidative stress in an intracerebroventricular streptozotocin model of Alzheimer's disease in rats. Clin Exp Pharmacol Physiol. 2003; 30(5-6):336-42.
64. Mohandas Rao KG, Muddanna Rao S, Gurumadhva Rao S. Enhancement of Amygdaloid Neuronal Dendritic Arborization by Fresh Leaf Juice of Centella Asiatica (Linn) During Growth Spurt Period in Rats. Evid Based Complement Alternat Med. 2009 Jun; 6(2):203-10.
65. Chen Y, Han T, Qin L, Rui Y, Zheng H. Effect of total triterpenes from Centella Asiatica on the depression behavior and concentration of amino acid in forced swimming mice. Zhong Yao Cai. 2003:26(12):870-3.
66. Oruganti M, Roy B, Singh K, Prasad R, Kumar S. Safety Assemment of Centella Asiatica in albino rats. Phcog J. 2010; 2(16):5-11.
67. Sharma PV. Dravyaguna Vijnana. Varanasi: Chaukhambha Bharati Academ; (in Hindi). 1995; 2:6-8.
68. Sharma PC, Yelne MB, Dennis TJ. Database on Medicinal plants used in Ayurveda and Sidha. Vol. 1. New Delhi: CCRAS, Dept. of AYUSH, Ministry of Health and Family Welfare, Govt. of India. 2000. p. 93-101.
69. Bhavaprakasha. Bhavaprakasha Nighantu, 1 st ed. Varanasi: Chaukhamba Publishers; 2007. p. 131.
70. Aithal HN, Sirsi M. Pharmacological investigation of Herpestis monneri. Indian J Pharmcol. 1961; 23:2-5.
71. Malhotra CL, Das PK. Pharmacological studies of Herpestis monneri. Indian J Med Res. 1959; 47(3):244-305.
72. Singh HK, Dhawan BN. Neuropsychopharmacological effects of the Ayurvedic Nootropic Bacopa monneri Linn. (Bramhi). Indian J Pharmacol. 1997; 29(5):359-65.
73. Sumathy T, Subramanian S, Govindaswamy S, Balakrishna K, Veluchamy G. Protective role of Bacopa monniera on morphine-induced hepatotoxicity in rats. Phytother Res. 2001; 15(7):643-5.
74. Raghav S, Singh H, Dalal PK, Srivastava JS, Asthana O P. Randomized controlled trial of Bacopa monniera extract in age-associated memory impairment. Indian J Psychiatry. 2006; 48(4):238-42.
75. Tripathi YB, Chaurasia S, Tripathi E, Upadhyay A, Dubey G P. Bacopa monniera Linn. as an antioxidant: Mechanism of action. Indian J Exp Biol. 1996; 34(6):523-6.
76. Devasagayam T P, Tilak JC, Boloor KK, Sane KS, Ghaskadbi SS, Lele RD. Free radicals and antioxidants in Human Health: Current status and future prospects. J Assoc Physicians India. 2004; 52(794804):4.
77. Bhattacharya SK, Bhattacharya A, Kumar A, Ghosal S. Antioxidant activity of Bacopa monniera in rat frontal cortex, striatum and hippocampus. Phytother Res. 2000; 14(3):174-9.
78. Rehni AK, Pantlya HS, Shri R, Singh M. Effect of Chlorophyll and aqueous extracts of Bacopa monniera and Valeriana wallichii on ischemia and reperfusion induced cerebral injury in mice. Indian J Exp Biol. 2007; 45:764-9.
79. Maciuk A, Bouchet MJ, Mazars G, Um BH, Anton R. Nootropic (Medhya) plants from ayurvedic pharmacopeia. Etudes chimiques et pharmacologiques 2002; 402-11.
80. Girish SA, Barabde U, Wadodkar S, Dorle A. Effect of Bramhi Ghrita, an poly-herbal formulation on learning and memory paradigms in experimental animals. Indian J Pharmacol. 2004; 36(3):159-62.
81. Hou CC, Lin SJ, Cheng J T, Hsu FL. Bacopasaponin G and bacopasides A, B, and C from Bacopa monniera. J Nat Prod. 2002; 65(12):1759-63.
82. Chakravarty AK, Garai S, Masuda K, Nakane T, Kawahara N. Bacopasides III-V: Three new triterpenoid glycosides from Bacopa monniera. Chem Pharm Bull. 2003; 51(2):215-7.
83. Choudhari DK, Parmar D, Kakkar P, Shukla R, Seth PK, Srimal RC. Antistress effects of bacosides of Bacopa monneri: Modulation of Hsp70 expression, superoxide dismutase and cytochrome P450 activity in rat brain. Phytother Res. 2002; 16(7):639-45.
84. Vohora D, Pal SN, Pillai KK. Protection from phenytoin induced cognitive deficits by Bacopa monnieri, a reputed Indian nootropic plant. J Ethnopharmacol. 2000; 71(3):383-90.
85. Shukla B, Khanna NK, Godhwani L. Effect of Brahmi Rasayan on the central nervous system. J Ethnopharmacol. 1987; 21(1):65-74.
86. Anbarasi K, Vani G, Balakrishna K, Devi CS. Effect of Bacoside A on Brain antioxidant status in cigarette smoke exposed rats. Life Sci. 2006; 78(12):1378.
87. Kar A, Panda S, Bharati S. Relative efficacy of three medicinal plant extracts in the alteration of thyroid hormone concentrations in male mice. J Ethnopharmacol. 2002; 81(2):281-5.
88. Agrawal A, Rajamanickam GV, Dubey G P. Ayurvedic Drugs in the Prevention and Management of Neuro-degenerative Disorders. 10-AYU-N10. PM70 P 20-4-2006 I.
89. Saraf MK, Prabhakar S, Khanduja KL, Anand A. Bacopa monniera Attenuates Scopolamine-Induced Impairment of Spatial Memory in Mice. Evidence-Based Complementary and Alternative Medicine. 2011; Article ID 236186.
90. Uabundit N, Wattanathorn J, Mucimapura S, Ingkaninan K. Cognitive enhancement and neuroprotective effects of Bacopa monnieri in Alzheimer's disease model. J Ethnopharmacol. 2010; 127(1):26-31.
91. Jyoti A, Sethi P, Sharma D. Bacopa monniera prevents from aluminium neuro-toxicity in the cerebral cortex of rat brain. J Ethnopharmacol. 2007; 111(1):56-62.
92. Saini N, Singh D, Sandhir R. Neuroprotective Effects of Bacopa monnieri in Experimental Model of Dementia. Neurochem Res. 2012; 37(9):1928-37.
93. Das A, Shanka G, Nath C, Pal R, Singh S, Singh H. A comparitaive study in rodents of standardized extracts of Bacopa monniera and Ginkobiloba: anti-cholinesterase and cognitive enhancing activities. Pharmacol Biochem Behav. 2002; 73(4):893-900.
94. Arpita Konar, 1 Akash Gautam, 2, M. K. Thakur. Bacopa monniera (CDRI-08) Upregulates the Expression of Neuronal and Glial Plasticity Markers in the Brain of Scopolamine Induced Amnesic Mice. Evidence-Based Complementary and Alternative Medicine. 2015. Article ID 837012.pp1-9.
95. Calabrese C, Gregory WL, Leo M, Kraemer D, Bone K, Oken B. Effects of a Standardized Bacopa monnieri Extract on Cognitive Performance, Anxiety, and Depression in the Elderly: A Randomized, Double-Blind, Placebo-Controlled Trial. Journal of Alternative and Complementary Medicine. 2008; 14(6):707-713.
96. Goswami S, Saoji A, Kumar N, Thawani V, Tiwari M, Thawani M. Effect of Bacopa monnieri on Cognitive functions in Alzheimer's disease patients. International Journal of Collaborative Research on Internal Medicine & Public Health. 2011; 3(4):285-293.
97. Sharma PC, Yelne MB, Dennis TJ. Database on Medicinal plants used in Ayurveda and Sidha. Vol. 3. New Delhi: CCRAS, Dept. of AYUSH, Ministry of Health and Family Welfare, Govt. of India. 2005. pp. 561-617.
98. Hatano T, Shintani Y, Shiota S, Tsuchiya T, Yoshida T. Phenolic constituents of licorice. VIII. Structures of glicophenone and glycoisof avanonem and effects of licorice, phenolics on Methicillin-resistant Staphylococcus aureus. Chem Pharm Bull. 2000; 48(9):1286-92. [PubMed: 10993226]
99. Ishii Y, Fuji Y. Effects of FM 100, a fraction of licorice root on serum gastrin concentration in rats and dogs. Jpn J Pharmacol. 1982; 32(1):23-7. [PubMed: 7087261]
100. Kuroda M, Mimaki Y, Sashida Y, Mae T, Kishida H, Nishiyama H, et al. Phenolics with PPAR-Ligand binding activity obtaind from Licorice (Glycyrrhiza uralensis roots) and ameliorative effects of Glycyrin on genetically diabetic KK-Ay mice. Bioorg Med Chem Lett. 2004; 13(24):4267-72. [PubMed: 14643306]
101. Kanda H, Sakurai M, Arima K. Licorice of "Shukuyaku Kanzou tou" induced pseudoaldosteronism. Hinyokika Kiyo. 2004; 50(3):215-7. [PubMed: 15148778]
102. Yoshida S, Takayama Y. Licorice induced hyperkalemia as a treatable cause of dropped head syndrome. Clin Neurol Neurosurg. 2003; 105(4):286-7. [PubMed: 12954548]
103. Sigurjonsdottir HA, Franzson L, Manhem K, Ragnarsson J, Sigurdsson G, Wallerstedt S. Licorice induced rise in Blood pressure, a linear dose response relationship. J Hum Hypertens. 2001; 15(8):549-52. [PubMed: 11494093]
104. Nussberger J. Investigating mineralocorticoids hypertension. J Hypertension. 2003; 2(Suppl):525-30.
105. Ravichandra V, Ahalyadevi, Adiga S. Evaluation of the effect of Glycyrrhiza glabra Linn. root extract on spatial learning and passive avoidance response in rats. Indian Drugs. 2007; 44(3):214-9.
106. Toshio F, Kazue S, Taro N. Preliminary evaluation of anti nephritis and radical scavenging activities of glabridin from Glycyrrhiza glabra Linn. Fitotherapia. 2003; 74:624-9.
107. Zhan C, Yang J. Protective effects of isoliquiritigenin in transient middle cerebral artery occlusion induced focal cerebral ischemia in rats. Pharmacol Res. 2006; 53(3):303-9. [PubMed: 16459097]
108. Vaya J, Belinky PA, Aviram M. Structural aspects of the inhibitory effect of glabridin on LDL oxidation. Free Rad Biol Med. 1998; 24(9):1419-29. [PubMed: 9641259]
109. Muralidharan P, Balamurugan G, Venu Babu. Cerebroprotective effect of Glycyrrhiza glabra Linn. root extract on Hypoxic rats. Bangladesh J Pharmacol. 2009; 4(1):60-4.
110. Devasagayam T P, Tilak JC, Boloor KK, Sane KS, Ghaskadbi SS, Lele RD. Free radicals and antioxidants in Human Health: Current status and future prospects. J Assoc Physicians India. 2004; 52:(794804):4. [PubMed: 15909857]
111. Rathee P, Chaudhary H, Rathee S, Rathee D. Natural memory boosters. Phcog Rev. 2008; 2(4):249-56.
112. Dhingra D, Parle M, Kulkarni SK. Memory enhancing activity of Glycyrrhiza Glabra in mice. J Ethnopharmacol. 2004; 91(2):361-5. [PubMed: 15120462]
113. Hasanein P. Glabridin as a major active isoflavan from Glycyrrhiza glabra (licorice) reverses learning and memory deficits in diabetic rats. Acta Physiol Hung. 2011; 98(2):221-30.
114. Cui YM, Ao MZ, Li W, Yu LJ. Effect of glabridin from Glycyrrhiza glabra on learning and memory in mice. Planta Med. 2008; 74(4):377-80.
115. Sharma PC, Yelne MB, Dennis TJ. Database on Medicinal plants used in Ayurveda and Sidha. Vol. 3. New Delhi: CCRAS, Dept. of AYUSH, Ministry of Health and Family Welfare, Govt. of India; 2005. pp. 256-81.
116. Nayampalli S, Ainapure SS, Nadkarni PM. Study of antiallergic acid Bronchodilator effects of Tinospora cordifolia. Indian J Pharm. 1982; 14 (1982):64-6.
117. Zhao T F, Wang X, Rimando AM, Che C. Folkloric medicinal plant: Tinospora sagittata var.cravaniana and Mohonia bealei. Planta Med. 1991; 57(5):505-3. [PubMed: 1798808]
118. Singh SS, Pandey SC, Srivastava S, Gupta VS, Patro B, Ghosh AC. Chemistry and Medicinal properties of Tinospora cordifolia (Guduchi). Indian J Pharmacol. 2003; 35(2):83-91.
119. Avinash KR, Manohar GM, Saibal KB. Rubia cordifolia, Fagonia cretica Linn. and Tinospora cordifolia exert neuroprotection by modulating the antioxidant system in rat hippocampal slices subjected to oxygen glucose deprivation. BMC Complement Altern Med. 2004; 4(1):11. [PMCID: PMC514713] [PubMed: 15310392]
120. Chulet R, Pradhan P. A review on Rasayana. Phcog Rev. 2009; 3(6):229-34.
121. Sharma V, Pandey D. Protective role of Tinospora cordifolia against lead-induced hepatotoxicity. Toxicol Int. 2010; 17(1):12-7. [PMCID: PMC2964743] [PubMed: 21042467]
122. Agarwal A, Malini S, Bairy KL, Rao MS. Effect of Tinospora cordifolia on Learning and Memory in normal and memory deficit rats. Indian J Pharmacol. 2002; 34(5):339-49.
123. Singh R P, Banergee S, Kumar PV, Raveesha KA, Rao AR. Tinospora cordifolia induces enzymes of carcinogen/ drug metabolism and antioxidant System, and inhibits lipid peroxidation in mice. Phytomedicine. 2006; 13(1):74-84. [PubMed: 16360936]
124. Stanely M, Prince P, Menon V P. Antioxidant action of Tinospora cordifolia root extract in alloxan diabetic rats. Phytother Res. 2001; 15(3):213-8. [PubMed: 11351355]
125. Patil M, Patki P, Kamath HV, Patwardhan B. Antistress activity of Tinospora cordifolia (Willd) Meirs. Indian drugs. 1997; 34(4):211-5.
126. Yalla Reddy Y, Mohana Lakshmi S, Saravana KA. Review on Effect of Natural Memory Enhancing Drugs On Dementia. Int J Phytopharmacol. 2010; 1:1-7.
127. Asuthosh A, Malini S, Bairy KL, Muddanna SR. Effect of Tinospora cordifolia on learning and memory in normal and memory deficits rats. Indian J Pharmacol. 2000; 34(5):339-49.
128. Prince PS, Kamalakkannan N, Menon V P. Restoration of antioxidant defence by ethanolic Tinospora cordifolia root extract in alloxan-induced diabetic liver and kidney. Phytother Res. 2004; 18(9):785-7. [PubMed: 15478189]
129. Devasagayam T P, Tilak JC, Boloor KK, Sane KS, Ghaskadbi SS, Lele RD. Free radicals and antioxidants in Human Health: Current status and future prospects. J Assoc Physicians India. 2004; 52:(794804):4. [PubMed: 15909857]
130. Manjrekar PN, Jolly CI, Narayanan S. Comparative studies of the immuno-modulatory activity of Tinospora cordifolia and Tinospora sinensis. Fitoterapia. 2000; 71(3):254-7. [PubMed: 10844163]
131. Bairy KL, Rao Y, Kumar KB. Efficacy of Tinospora cordifolia on Learning and Memory in Healthy Volunteers: A Double-Blind, Randomized, Placebo Controlled Study. Iranian Journal of Pharmacology and Therapeutics. 2004; 3(2):57-60.
132. Agarwal A, Malini S, Bairy KL, Rao MS. Effect of Tinospora Cordifolia on earning and Memory in Normal and Memory Deficit Rats. Indian Journal of Pharmacology. 2002; 34(5):339-49.
133. Upadhyay A, Kumar K, Kumar A, Mishra H. Tinospora Cordifolia (Willd.) Hook. F. and Thoms. (Guduchi) Validation of the Ayurvedic pharmacology through experimental and clinical studies. Int J Ayurveda Res. 2010; 1(2):112-21.
134. Mutalik, Madhav, Mutalik, Maitreyee. Tinospora cordifolia: Role in depression, cognition and memory. Australian Journal of Medical Herbalism. 2011; 23(4):168-73.
135. Billore KV, Yelne MB, Dennis TJ, Chaudhari BG. In: Database on Medicinal plants used In Ayurveda and Sidha. Joshi A, Prabhune YS, editors. Vol. 7. New Delhi: CCRAS, Dept. of AYUSH, Ministry of Health and Family Welfare, Govt. of India; 2005. pp. 433-41.
136. Part 1. Vol. 2. Delhi: Controller of Publications, Civil Lines; 1999. The Ayurvedic Pharmacopoeia of India; p. 155.
137. Bhatnagar M, Sisodia SS, Bhatnagar R. Antiulcer and antioxidant activity of Asparagus racemosus Willd and Withania somnifera Dunal in rats. Ann NY Acad Sci. 2005; 1056(1):261-78. [PubMed: 16387694]
138. Kumar A, Kulkarni SK. Protective effect of BR-16A, a polyherbal preparation against social isolation stress: Possible GABAergic mechanism. Phytother Res. 2006; 20(7):538-41. [PubMed: 16691632]
139. Rajagopalan V. Seminar on research in Ayurveda and Sidha. New Delhi: CCRAS; 1995.
140. Kalra Sanjeev. A study on the effect of Shankhapushpi compound and Satwavajaya Chikitsa in Chittodvega (generalized anxiety disorders) Dept. of Post Graduate studies in Manasa Roga, SDM College of Ayurveda and Hospital. Hassan, Rajiv Gandhi University of Health Sciences, Karnataka. 2006
141. Parsania S. A clinical study on the role of Jaladhara and Shankhapushpi (Convolvulus pleuricaulis) in the management of Chittodvega (anxiety disorder) Jamnagar: Dept. of Kayachikitsa, IPGT and RA, Gujarat Ayurveda University; 2001:35-7.
142. Kumar V. Potential Medicinal Plants for CNS Disorders: An Overview. Phytother Res. 2006; 20(12):1023-35. [PubMed: 16909441]
143. Indurwade NH, Biyani KR. Evaluation of comparative and combined depressive effect of Brahmi, Shankhpushpi and Jatamansi in mice. Indian J Med Sci. 2000; 54(8):339-41. [PubMed: 11143748]
144. Sharma K, Bhatnagar M, Kulkarni SK. Effects of Convolvulus pluricaulis choisy and Asparagus racemosus Willd. on learning and memory in young and old mice: A comparative evaluation. Journal of Experimental Biology. 2010; 48(5):479-485.
145. Bihaqi SW, Sharma M, Singh A P, Tiwari M. Neuroprotective role of Convolvulus pluricaulis on aluminium induced neurotoxicity in rat brain. Journal of Ethnopharmacology. 2009; 124(3):409-415.
146. Syed Waseem Bihaqi, Avninder Pal Singh, and Manisha Tiwari. Supplementation of Convolvulus pluricaulis attenuates scopolamineinduced increased tau and Amyloid precursor protein (Aβ PP) expression in rat brain. Indian J Pharmacol. 2012-44 (5):593-598.
147. Sharma PC, Yelne MB, Dennis TJ. Database on Medicinal plants used in Ayurveda and Sidha. Vol. 2. New Delhi: CCRAS Dept. of AYUSH, Ministry of Health and Family Welfare, Govt. of India; 2005. pp. 281-91.
148. Bhavaprakasha Nighantu. 1st ed. Varanasi: Chaukamba Publishers; 2007. Bhavamishra; p. 32.
149. Yong Q T, Yao ZC, Da GW, Xian MZ, Xiao JH. Sesquiterpenoids from Celastrus paniculatus. J Nat Prod. 1993; 56(1):122-5.
150. Kumar MH, Gupta YK. Antioxidant property of Celastrus paniculatus Willd. A possible mechanism in enhancing cognition. Phytomedicine. 2002; 9(4):302-11. [PubMed: 12120811]
151. Kalpana S P, Jayaprakash Effect of Celastrus paniculatus Willd. Seed on adjuvant induced arthritis. Phcog Mag. 2007; 3(11):177.
152. Gattu M, Boss KL, Terry AV, Buccafusco JL. Reversal of scopolamine induced deficits in navigational memory performance by the seed oil of Celastrus paniculatis. Pharmacol Biochem Behav. 1995; 57(4):793-9. [PubMed: 9259008]
153. Lekha G, Kumar B P, Rao SN, Arockiasamy I, Mohan K. Cognitive enhancement and Neuroprotective effect of Celastrus paniculatus Willd. seed oil (Jyothismati oil) on male Wistar rats. Journal of Pharmaceutical Science and Technology 2010; 2(2):130-8.
154. Part 1. Vol. 4. Delhi: Controller of Publications; 2004. The Ayurvedic Pharmacopoeia of India; pp. 62-3.
155. Sharma P V. Dravyaguna-vijnana. Vol. 2. Varanasi: Chaukhambha Bharati Academy; 1995. pp. 4-17. in Hindi.
156. Battu GR, Mamidipalli SN, Parimi R, Viriyala RK, Patchula R P, Mood LR. Hypoglycemic and anti-hyperglycemic effect of alclholic extract of Benin-casa hispida in normal and in alloxan induced diabetic rats. Phcog Mag. 2007; 3(10):101.
157. Bhalodia YS, Patel NJ, Patel RK, Vaghasiya JD, Jivani N P, Sheth NR. Benincasa cerifera ameliorates Renal ischemia/Reperfusion injury in hyperlipidemic rat. Phcog Res. 2009; 1(6):406-9.
158. Lim SJ. Effects of fractions of Benincasa hispida on antioxidant status in Streptozotocin induced Diabetic rats. Korean J Nutr. 2007; 40(4):295-302.
159. Sharma PC, Yelne MB, Dennis TJ. Database on Medicinal plants used in Ayurveda and Sidha. Vol. 1. New Delhi: CCRAS, Dept. of AYUSH, Ministry of Health and Family Welfare, Govt. of India; 2000. pp. 469-95.
160. Lai X Y, Liang H, Zhao Y Y. A survey of the studies on chemical constituents and pharmacological activities of Acorus plants. Zhongguo Zhong Yao Za Zhi. 2002; 27(3):161-5. 198. [PubMed: 12807142]
161. Shukla PK, Khanna V, Ali M, Maurya R, Khan M Y, Srimal RC. Neuroprotective effect of Acorus calamus against middle cerebral artery occlusion-induced ischaemia in rat. Hum Exp Toxicol. 2006; 25(4):187-94. [PubMed: 16696294]
162. Koo BS, Park KS, Ha JH, Park JH, Lim JC, Lee DU. Inhibitory effects of the fragrance inhalation of essential oil from Acorus gramineus on central nervous system. Biol Pharm Bull. 2003; 26(7):978-82. [PubMed: 12843622]
163. Mukherjee PK, Kumar V, Mal M, Houghton PJ. In vitro acetylcholinesterase inhibitory activity of the essential oil from Acorus calamus and its main constituents. Planta Med. 2007; 73(3):283-5. [PubMed: 17286241]
164. Mazza G. Gas chromatographic and mass spectrometry studies of the constituents of the rhizome of Acorus calamus II, The volatile constituents of essential oil. J Chromatogr. 1985; 328:179-94
165. Willamson EM, Evans FJ. Potter's new cyclopedia of botanical drugs and preparations. Walden, Essex: Saffron Walden; 1988.
166. Jayaraman R, Anitha T, Vishal DJ. Analgesic and Anticonvulsant effects of Acorus calamus roots in mice. Int J Pharm Tech Res. 2010; 2(1):552-5.
167. Palani S, Raja S, Praveen KR, Venkadesan D, Devi K, Sivaraj A, et al. Therapeutic efficacy of antihepatotoxic and antioxidant activities of Acorus calamus on acetaminophen-induced toxicity in rats. Int Journal Integr Biol. 2009; 7(1):39-44.
168. Acuna UM, Atha DE, Ma J, Nee MN, Kennelly EJ. Antioxidant capacities of ten edible North American plants. Phytother Res. 2002; 16(1):63-5. [PubMed: 11807968]
169. Shahin SA, Naresh K, Abhinav L, Angad S, Hallihosur S, Abhishek S, et al. Review Indian medicinal herbs as sources of antioxidants. Food Res Int. 2008; 41(1):1-15.
170. Aqil F, Zahin M, Ahmad I. Antimutagenic activity of methanolic extracts of four ayurvedic medicinal plants. Indian J Exp Biol. 2008; 46(9):668-72. [PubMed: 18949897]
171. Ignacimuthu S, Ayyanar M, Sivaraman S. Ethnobotanical investigations among tribes in Madurai District of Tamil Nadu (India). J Ethnobiol Ethnomed. 2006; 2(s1):25. [PMCID: PMC1475842] [PubMed: 16689985]
172. Chellaiah M, Muniappan A, Nagappan R, Savarimuthu I. Medicinal plants used by traditional healers in Kancheepuram District of Tamil Nadu, India. J Ethnobiol Ethnomed. 2006; 2(1):43. [PMCID: PMC1615867] [PubMed: 17026769]
173. Fozdar NG, Doongaji, Bauadia VN, Vahia NS. Preliminary of report an indegenious drug Acorus calamus in psychiatric disorders. Indian J Psychiatry. 1962; 4(1):12.
174. Pulok kumar muKherjee, Venkatesan kumar, Mainak mal, Peter J Haughton. Invitro acetylcholinesterase inhibitory activity of the essential oil from Acorus calamus and its main constituents. Letter. Planta Med. 2007; 73(3):283-5.
175. Vijayapandi et al., Afr J Tradit Complement Altern Med. (2013); 10(1):95-101
176. Chen Huanga, c, 1, WeiGuang Lic, 1, XiaoBing Zhangb, Li Wanga, TianLe Xuc, Dazheng Wua, Yong L. Alphaasarone from Acorus gramineus alleviates epilepsy by modulating AType GABA receptors. Neuropharmacology. 2013; 65:1-11.
177. Ravindran PN, Balachandran I. Under utilized medicinal spices. Spice India. 2004; 17(12):2-14.
178. Riaz M, Chaudhary FM. Chemistry of medicinal plants of genus acorus (family Aracae) Hamdard Medicus. 1995; 38:50-62.
179. Manikandan S, Srikumar R, Jeya Parthasarathy N, Sheela Devi R: Protective effect of Acorus calamus Linn on free radical scavengers and lipid peroxidation in discrete regions of brain against noise stress exposed rat. Biol Pharm Bull. 2005,28(12):2327-30.
180. Tippani R, Porika M, Rao AV, Abbagani S, Yellu NR, Tammidala C: Analgesic activity of root extract of Acorus calamus Linn. Pharmacologyonline. 2008; 3:240-3.
181. Yang L, Li S, Huang Y, Liang J, Wang Y: Effects of Acorus gramineus and its component, alpha-asarone, on apoptosis of hippocampal neurons after seizure in immature rats. Neural Reg Res. 2008; 3(1):19-24.
182. Geetha RK, Vasudevan DM: Inhibition of lipid peroxidation by botanical extracts of Ocimum sanctum: In vivo and in vitro studies. Life Sci. 2004; 76(1):21-8.
183. Hazra R, Ray K, Guha D: Inhibitory role of Acorus calamus in ferric chloride-induced epileptogenesis in rat. Hum Exp Toxicol. 2007; 26(12):947-53.
184. Shukla PK, Khanna VK, Ali MM, Maurya R, Khan M Y, Srimal RC: Neuroprotective effect of Acorus calamus against middle cerebral artery occlusion-induced ischaemia in rat. Hum Exp Toxicol. 2006; 25(4):187-94.
185. Young W: Role of calcium in central nervous system injuries. J Neurotrauma. 1992; 9:9-25.
186. Gilani AU, Shah AJ, Ahmad M, Shaheen F: Antispasmodic effect of Acorus calamus Linn. is mediated through calcium channel blockade. Phytother Res. 2006; 20(12):1080-4.
187. Muthuraman, Singh N. Attenuating effect of Acorus calamus extract in chronic constriction injury induced neuropathic pain in rats: an evidence of anti-oxidative, anti-inflammatory, neuroprotective and calcium inhibitory effects. BMC Complementary and Alternative Medicine. 2011; 11(1):24.
188. Ilaiyaraja N, Dongzagin Singsit, Farhath K. Effect of rhizome extract of Acorus calamus on depressive condition induced by forced swimming in mice. International Journal of phytomedicine. 2012; 4(3):319-25.
189. Bellore KV, Yelne MB, Dennis TJ, Chaudhari BG. Database on Medicinal plants used in Ayurveda and Sidha. Vol. 7. New Delhi: CCRAS, Dept. of AYUSH, Ministry of Health and Family Welfare, Govt. of India; 2005. pp. 135-57.
190. Bhavaprakasha Nighantu. 1st ed. Varanasi: Chaukamba Publishers; 2007. Bhavaprakasha; p. 65.
191. Bagchi A, Oshima Y, Hikino H. Neoligans and lignans of Nardostachys Jatamansi Roots. Planta Med. 1991; 57(1):96-7. [PubMed: 17226134]
192. Uniyal MR, Issar RK. Commercially and traditionally important medicinal plants of Mandakini valley of Uttarkhand Himalayas. J Res Indian Med. 1969; 4:83-96.
193. Chatterjee A, Basak B, Saha M, Dutta U, Mukhopadhyay C, Banerji J, et al. Structure and Stereo-chemistry of Nardostachysin, A New Terpenoid ester constituent of the Rhizomes of Nardostachys Jatamansi. J Nat Prod. 2000; 63(11):1531-3. [PubMed: 11087600]
194. Joshi H, Parle M. Nardostachys jatamansi improves learning and memory in mice. J Med Food. 2006; 9(1):113-118. [PubMed: 16579738]
195. Ahamad M, Saleem S, Ahamad AS, Ansari MA, Yousuf S, Hoda MN, et al. Neuroprotective effect of Withania sominifera on 6-hydroxydopamine induced Parkinsonism in rats. Hum Exp Toxicol. 2005; 24(3):137-47. [PubMed: 15901053]
196. Mukherjee PK, Kumar V, Houghton PJ. Screening of Indian medicinal plants for acetylcholinesterase inhibitory activity. Phytother Res. 2007; 21(12):1142-5.
197. Joshi H, Parle M. Nardostachys jatamansi improves learning and memory in mice. J Med Food. 2006; 9(1):113-8.
198. Karkada G, Shenoy KB, Halahalli H, Karanth KS. Nardostachys jatamansi extract prevents chronic restraint stress-induced learning and memory deficits in a radial arm maze task. J Nat Sci Biol Med. 2012; 3(2):125-32.
199. Faiyaz A, Narendra Sharath Chandra JNb. Asna Urooja and Rangappa K.S.. In vitro antioxidant and anticholinesterase activity of Acorus calamus and Nardostachys jatamansi rhizomes. Journal of Pharmacy Research. 2009; 2(5):830-33.
200. Ali A, Dua Y, Siddiqui AW, Sultana S, Rafiullah MR. Inhibition of benzoyl peroxide-induced cutaneous oxidative stress, toxicity and ear edema in mice by Nardostachys Jatamansi. Pharm Biol. 2005; 43(6):533-9.
201. Muzamil A, Seema Y, Badruzzaman MK, Md. Nasrul H, Abdullah SA, Mubeen AA, Tauheed I, Ashok KA, Fakhrul I. Attenuation by Nardostachys jatamansi of 6-hydroxydopamineinduced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies. Bharmacology Biochemistry and Behavior. 2006; 83(1):150-60.
202. Warrier PK, Nambiar VPK, Ramankutty C. Indian Medicinal Plants: A Compendium of 500 Species. Orient Longman, Madras, India (1996).
203. Mishra LC, Singh BB, Dagenais S. Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Altern Med Rev 5. 2000; 5(4):334-46.
204. Yousuf SK, Majeed R, Ahmad M, Sangwan P, Purnima B, Saxsena AK, et al. Taneja, Ring. A structural modified derivatives of withaferin A and the evaluation of their cytotoxic potential. Steroids. 2011; 76(10):1213-22.
205. Mayola E, Gallerne C, Esposti DD, Martel C, Pervaiz S, Larue L, et al. Withaferin A induces apoptosis in humanmelanoma cells through generation of reactive oxygen species and downregulation of Bcl-2, apoptosis. 2011; 16(10):1014-27.
206. Thaiparambil J T, Bender L, Ganesh T, Kline E, Patel P, Liu Y, Tighiouart M, Vertino PM, Harvey RD, Garcia A, Marcus AI. Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation. Int J Cancer. 2011; 129(11):2744-55.
207. Stan SD, Zeng Y, Singh SV. Ayurvedic medicine constituent withaferin A causes G2 and M phase cell cycle arrest in human breast cancer cells. Nutr Cancer. 2008; 60(s1):51-60.
208. Mohan R, Hammers HJ, Bargagna-Mohan P, Zhan XH, Herbstritt CJ, Ruiz A, Zhang L, Hanson AD, Conner B P, Rougas J, Pribluda VS. Withaferin A is a potent inhibitor of angiogenesis, Angiogenesis. 2004; 7(2):115-22.
209. Sharanbasappa D, Shivsharan BD, Ravichandra V, Badamaranahalli SS, Chab-banahalli SC. Withania somnifera (Ashwagandha) in neurobehavioural disorders induced by brain oxidative stress in rodents: a systematic review and meta-analysis. Journal of Pharmacy and Pharmacology. 2015; 67:879-99.
210. Kushwaha S, Soni VK, Singh PK, Bano N, Kumar A, Sangwan RS, S. Misra-Bhattacharya, Withania somnifera chemotypes NMITLI 101R, NMITLI 118R, MITLI 128R and Withaferin A protect Mastomys coucha from Brugia Malayi infection, Parasite Immunol. (2011), http://dx.doi.org/10.1111/j.1365-3024.2011.01352.x.
211. Sudhir S, Budhiraja RD. Comparison of the protective effect of Withaferin-'A' and hydrocortisone against CCL4 induced hepatotoxicity in rats. Indian J Physiol Pharmacol. 1992; 36(2):127-129.
212. Kuboyama T, Tohda C, Komatsu K, Neuritic regeneration and synaptic reconstruction induced by withanolide A. Br J Pharmacol. 2005; 144(7):961-71.
213. Tohda C, Kuboyama T, Komatsu K, Search for natural products related to regeneration of the neuronal network, Neurosignals. 2005; 14(1-2):34-45.
214. Bhattacharya SK, Bhattacharya A, Sairam K, Ghoshal S. Anxiolytic-antidepressant activity of Withania somnifera glycowithanolides: an experimental study. Phytomedicine. 2000; 7(6):463-9.
215. Sehgal N, Gupta A, Valli RK, Joshi SD, Mills J T, Hamel E, Khanna P, et al. Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver. Proc Natl Acad Sci U S A. 2012; 28; 109(9):3510-5.
216. Jaiprakasam B, Padmanabhan K, Nair MG. Withanamides in Withania somnifera fruit protects PC-12 cells from beta-amyloid responsible for Alzheimer's disease. Phytother Res. 2010; 24(6):859-63.
217. Kumar S, Harris RJ, Seal CJ, Okello EJ: An aqueous extract of Withania somnifera root inhibits amyloid beta fibril formation in vitro. Phytother Res. 2012,26:113-7.
218. Singh RH, Narsimhamurthy K, Singh G. Neuronutrient impact of Ayurvedic Rasayana therapy in brain aging. Biogerontology. 2008; 9(6):369-74.
219. Molloy SA, Rowan EN, O'Brien J T, McKeith IG, Wesnes K, Burn DJ. Effect of levodopa on cognitive function in Parkinson's disease with and without dementia and dementia with Lewy bodies. J Neurol Neurosurg Psychiatr. 2006; 77:1323-8.
220. Kumar KVA, Srinivasan KK, Shanbhag T, Rao SG. Aphrodisiac activity of the seeds of Mucuna pruriens. Indian Drug. 1994; 31:321-7.
221. Manyam BV, Dhanasekaran M, Hare TA. Neuroprotective effects of the antiparkinson drug. Mucuna Pruriens Phytother Res. 2004; 18(9):706-712.
222. Sharma ML, Chandhoke N, Ray Ghatak BJ, Jamwal KS, Gupta O P, Singh GB. Pharmacological screening of Indian medicinal plants. Indian J Exp Biol. 1978; 16:228-35.
223. Misra L, Wagner H. Extraction of bioactive principle from Mucuna pruriens seeds. Indian J Biochem Biophys. 2007; 44(1):56-60.
224. Kamla KS, Abbas AM, Mohammad KA, Shyam PJ, Satya NS, Sarvada C T. Mucuna pruriens Reduces Stress and Improves the Quality of Semen in Infertile Men. eCAM. 2010; 7(1) 137-144.
225. Satyndra K Y, Jay P, Shikha C, Surya PS. Mucuna pruriens seed extract reduces oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in paraquatinduced Parkinsonian mouse model. Neurochemistry International. 2013; 62(8):1039-47.
226. RH singh. Ayurvediya manas vijnan. Varanasi. Chaukhamba publications. 1986.
227. Kulkarni R, Girish KJ, Kumar A. Nootropic herbs (Medhya Rasayana) in Ayurveda: An update. Phcog Rev [serial online] [cited 2012 Oct 17] 2012; 6(12):147-53.
228. Bhava pN, Bhavaprakasha, Hindi commentary, Chunekar KC, Guduchyadi Varga (281), pg.461, Chaukhambha Bharati Academy, Varanasi (2002).
229. Bhava pN, Bhavaprakasha, Hindi commentary, Chunekar KC, Guduchyadi Varga (189), pg.393, Chaukhambha Bharati Academy, Varanasi (2002).
230. Bhava pN, Bhavaprakasha, Hindi commentary, Chunekar KC, Haritakyadi Varga (31), pg.6, Chaukhambha Bharati Academy, Varanasi (2002).